RO7616789
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7616789, covering 2025-03-10 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas [Phase 1]